The number of deaths from Covid-19 among children aged 18 or younger reached 44 as of Thursday, the government said Thursday.On Thursday, the Central Disease Control Headquarters (CDCH) released the analysis on Covid-19 deaths among children and adolescents aged 18 or younger.The nation reported the
Korean Journal of Radiology (KJR) ranked top among radiology journals using country or continent names by recording the highest impact factor (IF) last year.IF, also known as journal impact factor (JIF), is a scientometric index calculated by Clarivate that reflects the mean number of citations of a
ABL Bio said it would disclose pre-clinical data of ABL602, an acute myeloid leukemia (AML) treatment, at the European Society for Medical Oncology (ESMO 2022) meeting in early September.The pre-clinical data has been selected as one of the key oral presentations in hemato-oncology at ESMO 2022 in P
The six-month grace period for SillaJen to improve business practices, granted by the financial regulator, ended as of Thursday. As a result, investors are paying attention to whether the regulator will allow the company’s stock trading resumption.Thursday marked the end of the six-month grace perio
Cold medicines, including antipyretics and anti-inflammatory analgesics, are going extremely short due to the recent spike in Covid-19 cases in Korea.However, the Ministry of Food and Drug Safety is refraining from intervening and letting drugmakers and distributors handle the supply shortage themse
A team of researchers at the Korea Research Institute of Bioscience and Biotechnology Research (KRIBB) has developed a biosensor capable of monitoring serotonin levels in real-time for diagnosing depression.Depression has been linked to the imbalance of neurotransmitters in the body, genetic predisp
Samsung Bioepis and Organon said Wednesday that the U.S. Food and Drug Administration had approved their citrate-free high-concentration (100 mg/mL) formulation of Hadlima (Ingredient: adalimumab-bwwd), a biosimilar of Humira.The FDA approved the citrate-free high-concentration version of Hadlima ba
As the Covid-19 summer resurge continues, the number of daily new cases surged above 180,000 on Wednesday, nearing the peak estimate of the re-infestation expected by the quarantine authorities.On Wednesday, the Korea Disease Control and Prevention Agency (KDCA) confirmed 180,803 new virus cases rai
Gilead’s subsidiary Immunomedics, the original developer of a new anticancer drug Trodelvy (ingredient: sacituzumab govitecan), retrieved its sales rights in Asia from Everest Medicines. The move gives Gilead the sales right of Trodelvy in the global market, including Korea.Everest Medicines Korea,
Genexine said on Tuesday that it has completed the first patient dosing of the triple combination DNA cancer vaccine therapeutic for phase 2 trials.Genexine will combine its GX-188E and GX-I7 with BMS’ global immuno-anticancer drug Opdivo in the clinical trial. Professor Kim Hye-ryun of Yonsei Cance
The second quarter earnings of major Korean diagnostic kit manufacturers fell from the same period last year, according to industry sources.Diagnostic kit makers’ sales and operating profits increased in the first quarter due to the resurge of the Covid-19 virus since the beginning of this year. How
Hanmi Pharmaceutical said it would begin a local phase 3 trial of poziotinib to treat a certain type of non-small cell lung cancer (NSCLC). Attention is on whether the drugmaker will complete the confirmatory trial, a condition required by the U.S. FDA to obtain marketing approval.On Tuesday, the Mi
A new project in the U.K. is drawing the world’s attention as it aims to propose effective healthcare and welfare for people with learning disabilities who suffer from multimorbidity by using artificial intelligence (AI).The project is called “DECODE” (Data-driven machinE-learning aided stratificati
Samsung Life Science Fund said on Wednesday that it would invest $15 million (19 billion won) in Senda Biosciences, a U.S. biotech company specializing in natural nanoparticle-based drug delivery technology, to develop next-generation biopharmaceuticals.Senda is a merger of four natural nanoparticle
Novartis Korea said Beovu (ingredient: brolucizumab), a treatment for wet, age-related macular degeneration (AMD), obtained the Ministry of Food and Drug Safety approval for expanded indication to also treat diabetic macular edema on Aug. 4.The ministry granted the expanded indication approval based
Korea had the highest number of new virus cases per 1 million people worldwide last week, a global Covid-19 statistic tracking site said Sunday.According to Our World in Data, an international statistics site, as of last week, Korea had 16,452 new Covid-19 cases per 1 million people, recording the h
Kolon TissueGene will receive additional funds through a capital increase to be participated in by the Kolon Group and its Chairman Lee Woong-yeol.According to TissueGene, the company issued a capital increase of about 38.8 billion won ($29.6 million) last Friday. The number of shares issued followi
After the government granted health insurance benefits for CAR-T cell therapy Kymriah, the Asan Medical Center (AMC) opened the nation’s first CAR-T cell treatment center.AMC said Tuesday that its cancer hospital opened the CAR-T center and began reimbursing Kymriah treatment, certified by Novartis.
Empirical antibiotic therapy, or the use of antibiotics before testing bacterial infection in Covid-19 patients, does not improve Covid-19 patients’ clinical outcomes, a study showed.Empirical antibiotic therapy is defined as the use of antibiotics within 48 hours after hospitalization before microb
Binex said Tuesday it has signed a contract development manufacturing organization (CDMO) agreement with the Seoul National University Hospital (SNUH) to jointly conduct the latter’s research-driven hospital project to develop a new drug candidate RS22802.The company expects to develop it into anti-